Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Bolt Biotherapeutics Strategic Update Conference Call. At this time, all participants are in a listen only mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Tang Capital Management Kevin C. Tang | 3,812,773 | $2,470,677 | 0.17% | |
2. | Vivo Capital Albert Cha And Frank Kung | 3,521,291 | $2,281,797 | 0.18% | |
3. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 1,049,153 | $679,851 | 0.13% | |
4. | Adage Capital Management Phill Gross And Robert Atchinson | 500,000 | $324,000 | 0% | |
5. | Newtyn Management Noah Levy And Eugene Dozortsev | 468,910 | $303,854 | -66% | 0.04% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.78 | 2,500 | Officer | 8,918 | 2023-12-06 | Filing | |
$0.78 | 2,500 | Officer | 46,612 | 2023-12-06 | Filing | |
$1.18 | 2,070 | Officer | 44,112 | 2023-06-06 | Filing | |
$0.78 | 2,500 | Officer, Director | 12,859 | 2023-12-06 | Filing | |
$1.18 | 2,500 | Officer, Director | 10,359 | 2023-06-06 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.86 | 14,934 | Director | 251,522 | 2023-11-30 | Filing | |
$0.91 | 3,131 | Director | 266,456 | 2023-11-29 | Filing | |
$0.86 | 108,145 | Director | 1,821,483 | 2023-11-30 | Filing | |
$0.91 | 22,674 | Director | 1,929,628 | 2023-11-29 | Filing | |
$0.90 | 236 | Director | 269,587 | 2023-11-21 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 2,754,437 | $3,084,969 | 0.17% | |
2. | 1,891,467 | $2,118,443 | 0.53% | |
3. | 1,166,952 | $1,306,986 | 0.81% | |
4. | 931,129 | $1,042,864 | 0% | |
5. | 719,546 | $805,891 | 0.05% |